Skip to main content
. 2019 Oct 3;267(1):133–137. doi: 10.1007/s00415-019-09558-9

Table 1.

Patient characteristics for cases (cSAH) and controls

cSAH (n = 19) Controls (n = 76) Confirmed TIA subgroup (n = 30) p value* Univariable OR** (95% CI)
Age: mean (SD) 68.9 (9.03) 68.9 (8.9) 72.6 (7.76) 1.0
Male sex: n (%) 11 (55) 44 (55) 19 (63) 1.0
Atrial fibrillation 1 (5) 4 (5) 2 (7) 1.0 1.0 (0.1–9.5)
Excessive alcohol 0 (0) 2 (3) 0 (0) 0.9 0.8 (0.04–16.6)
Hypertension 10 (53) 54 (59) 20 (67) 0.1 0.5 (0.2–1.3)
Previous stroke/TIA 1 (5) 14 (18) 7 (23) 0.2 0.3 (0.03–2.0)
Smoker 0 (0) 5 (7) 4 (13) 0.5 0.3 (0.01–6.3)
Ex-smoker 5 (26) 20 (26) 5 (17) 1.0 1.0 (0.3–3.1)
Diabetes mellitus 0 (0) 8 (11) 2 (7) 0.3 0.2 (0.01–3.7)
Hypercholesterolaemia 3 (16) 40 (53) 18 (60) 0.008 0.17 (0.05–0.6)
Antithrombotic therapy, n (%) 5 (26) 24 (32) 11 (37) 0.7 0.8 (0.3–2.4)

*Difference in proportions for cSAH vs controls

**For cSAH vs controls